Dr. Francesca Filbey is currently an Associate Professor and Director of Cognitive Neuroscience Research of Addictive Disorders at the Center for BrainHealth, School of Behavioral and Brain Sciences at the University of Texas at Dallas and Adjunct Associate Professor at the University of Texas Southwestern Medical School, Department of Psychiatry. She also holds the Endowed Bert Moore Chair of BrainHealth. Dr. Filbey has received continued federal and non-federal funding over the last 15 years with over 70 peer-reviewed publications, an authored book, an edited book and several book chapters. She is on the Editorial Board for the American Journal of Drug and Alcohol Abuse, Psychology of Addictive Behaviors, a Review Editor for Frontiers in Behavioral and Psychiatric Genetics and has been the Guest Editor for several scientific journals. She is an active grant reviewer for several national and international funding agencies including chartered membership in the NIH Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section (NPAS). She is also a voted Associate Member of the American College of Neuropsychopharmacology and a Member of the College on Problems of Drug Dependence. Dr. Filbey received her PhD in Experimental Neuropsychology from the Institute of Psychiatry, King’s College London and a postdoctoral fellowship in Human Neuroimaging at the National Institute of Mental Health, NIH.
The overarching goal of Dr. Filbey’s research is to advance the understanding of biobehavioral mechanisms of addictive disorders towards the improvement of early detection and intervention. Her lab utilizes multimodal tools including MRI, EEG, neuromodulatin and genome-wide analyses to examine cognitive mechanisms across populations of substance abusers, binge eaters and risk-taking youth and adults.
Dr. Filbey’s studies incorporate translational approaches from the fields of cognitive neuroscience, neuroimaging, genetics, neuropharmacology, psychology, and psychiatry. Specifically, taking advantage of technological advancements, Dr. Filbey combines genomic and neuroimaging approaches to determine neurobiological markers for addiction. These projects move beyond simple classifications of presence or absence of a disorder by applying a “deep phenotyping” approach that consists of continuous variables from cognitive assessments in addition to biological processes. To that end, Dr. Filbey utilizes a stepwise approach that (1) defines the neural mechanisms that underlie behavioral symptoms of addictive disorders, then, (2) determines the individual variability (genetic and environmental factors) that modulate these mechanisms, placing one at risk for these disorders. As a whole, these projects aim to advance understanding of biobehavioral mechanisms of addictive disorders.